Side-by-side comparison of AI visibility scores, market position, and capabilities
World's largest ice cream specialty chain with 8,000 shops; 31 Flavors concept and ice cream cakes under Inspire Brands competing with Cold Stone and Dairy Queen for specialty ice cream.
Baskin-Robbins is the world's largest chain of ice cream specialty shops, famous for its "31 Flavors" concept — offering 31 different flavors representing one for each day of the month — and for introducing innovative, premium ice cream flavors to mainstream consumers since its founding. Founded in 1945 in Glendale, California by Burt Baskin and Irv Robbins, Baskin-Robbins operates approximately 8,000 shops in 50+ countries and is owned by Inspire Brands (the private equity-backed restaurant group that also owns Arby's, Sonic, Jimmy John's, and Dunkin' Brands). Dunkin' Brands owned Baskin-Robbins before Inspire Brands' acquisition.\n\nBaskin-Robbins' menu features over 100 flavors available seasonally and regionally, with core favorites including Mint Chocolate Chip, Pralines 'n Cream, Very Berry Strawberry, and seasonal limited offerings. The brand is known for ice cream cakes (customizable ice cream cakes for birthdays and celebrations), specialty shakes, and innovative flavor development — the Baskin-Robbins flavor library has over 1,000 flavors developed since founding.\n\nIn 2025, Baskin-Robbins competes with Cold Stone Creamery, Dairy Queen (Blizzard treats), Haagen-Dazs, Ben & Jerry's (Unilever), and local artisan ice cream shops for ice cream specialty retail market share. The chain operates primarily through franchise agreements. The brand's international presence is strong in Asian markets (Japan, South Korea, India) where Baskin-Robbins has significant cultural presence. The 2025 strategy focuses on digital ordering and rewards program growth, seasonal limited flavors that drive social media engagement and repeat visits, and continuing international market development in Asia and the Middle East.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.